2024    2023    2022    2021    2020    2019    2018    2017    2016   

2012

Articles

41 - 

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial.

Cécile Goujard, Dominique Emilie, Caroline Roussillon, Véronique Godot, Chrisitine Rouzioux, Alain Venet, Céline Colin, Gilles Pialoux, Pierre-Marie Girard, Valérie Boilet et al.

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial. AIDS. Official journal of the international AIDS Society, 2012, 26 (15), pp.1895-905.

DOI : https://doi.org/10.1097/QAD.0b013e32835844d9

Pubmed : 22842994

 

42 - 

DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry.

Dan Gu, Robert J. Turesky, Yeqing Tao, Sophie Langouët, Gwendoline Nauwelaers, Jian-Min Yuan, Douglas Yee, Mimi C. Yu

DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry. Carcinogenesis, 2012, 33 (1), pp.124-30.

DOI : https://doi.org/10.1093/carcin/bgr252

Pubmed : 22072616

 

43 - 

Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66

J. Guillemot, E Thouënnon, M. Guérin, V. Vallet-E.rdtmann, A. Ravni, M Montéro-Hadjadje, H. Lefebvre, M. Klein, M. Muresan, N. G Seidah et al.

Journal of Molecular Endocrinology, 2012, 48 (2), pp.115 - 127.

DOI : https://doi.org/10.1530/JME-11-0077

 

44 - 

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.

Jean-Philippe Guégan, Christophe Frémin, Georges Baffet

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. International Journal of Hepatology, 2012, 2012, pp.328372.

DOI : https://doi.org/10.1155/2012/328372

Pubmed : 23133759

 

45 - 

Occurrence and toxicity of disinfection byproducts in European drinking waters in relation with the HIWATE epidemiology study.

Clara H Jeong, Elizabeth D Wagner, Vincent R Siebert, Sridevi Anduri, Susan D Richardson, Eric J Daiber, a Bruce Mckague, Manolis Kogevinas, Cristina M Villanueva, Emma H Goslan et al.

Occurrence and toxicity of disinfection byproducts in European drinking waters in relation with the HIWATE epidemiology study. Environmental Science and Technology, 2012, 46 (21), pp.12120-8.

DOI : https://doi.org/10.1021/es3024226

Pubmed : 22958121

 

46 - 

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

Raoul Herbrecht, Denis Caillot, Catherine Cordonnier, Anne Auvrignon, Anne Thiébaut, Benoît Brethon, Mauricette Michallet, Nizar Mahlaoui, Yves Bertrand, Paul Preziosi et al.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Journal of Antimicrobial Chemotherapy, 2012, 67 (11), pp.2731-8.

DOI : https://doi.org/10.1093/jac/dks266

Pubmed : 22850692

 

47 - 

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.

Roch Houot, Steven Le Gouill, Mario Ojeda Uribe, C. Mounier, Stéphane Courby, Caroline Dartigeas, K. Bouabdallah, M. Alexis Vigier, Marie Pierre Moles, Olivier Tournilhac et al.

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. Annals of Oncology, 2012, 23 (6), pp.1555-61.

DOI : https://doi.org/10.1093/annonc/mdr450

Pubmed : 22012966

 

48 - 

IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology.

Muhammad I Arshad, Claire Piquet-Pellorce, Michel Samson

IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver International, 2012, 32 (8), pp.1200-10.

DOI : https://doi.org/10.1111/j.1478-3231.2012.02802.x

Pubmed : 22530772

 

49 - 

TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis.

Muhammad Imran Arshad, Claire Piquet-Pellorce, Annie L'Helgoualc'H, Michel Rauch, Solène Patrat-Delon, Frédéric Ezan, Catherine Lucas-Clerc, Sabrina Nabti, Agnès Lehuen, Francisco Javier Cubero et al.

TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology, 2012, 56 (6), pp.2353-62.

DOI : https://doi.org/10.1002/hep.25893

Pubmed : 22961755

 

50 - 

Guidelines for the use and interpretation of assays for monitoring autophagy.

Daniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, Robert T Abraham, Abraham Acevedo-Arozena, Khosrow Adeli, Lotta Agholme, Maria Agnello, Patrizia Agostinis, Julio A Aguirre-Ghiso et al.

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2012, 8 (4), pp.445-544.

DOI : https://doi.org/10.4161/auto.8.4.19496

Pubmed : 22966490